TITLE

Streptozotocin treatment of malignant islet cell tumour

AUTHOR(S)
Stanley, N N; Marks, V; Kreel, L; McIntyre, N
PUB. DATE
September 1970
SOURCE
British Medical Journal;9/5/1970, Vol. 3 Issue 5722, p562
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64097894

 

Related Articles

  • Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients. Broder, Lawrence E.; Carter, Stephen K.; Broder, L E; Carter, S K // Annals of Internal Medicine;Jul73, Vol. 79 Issue 1, p108 

    Part II. Presents a study which examined the outcome of treatment of pancreatic islet cell carcinoma with streptozotocin. Patients and methods; Results; Discussion.

  • Forced diuresis to reduce nephrotoxicity of streptozotocin in the treatment of advanced metastatic insulinoma. Tobin, M.V.; Warenius, H.M.; Morris, A.I. // British Medical Journal (Clinical Research Edition);5/2/1987, Vol. 294 Issue 6580, p1128 

    Examines the efficacy of diuresis on reducing nephrotoxicity of streptozotocin in metastatic insulinoma treatment. Practicability of surgical treatment on islet cell tumor patients; Effect of diazoxide on preventing hypoglycemia; Possibility on renal function deterioration following treatment.

  • Pancreatic endocrine tumours. Carter, D.C. // British Medical Journal (Clinical Research Edition);3/7/1987, Vol. 294 Issue 6572, p593 

    Focuses on the development of pancreatic endocrine tumours. Relation of the cell islet tumours and peptic ulceration; Efficiency of amine precursor uptake and decarboxylation for digestion control and carbohydrate metabolism; Efficacy of cytotoxic treatment.

  • ISLET CELL TUMORS OF THE PANCREAS. Feldman, Maurice; Weinberg, Tobias; Feldman Jr., Maurice // American Journal of Gastroenterology;Oct1954, Vol. 22 Issue 4, p320 

    Explains the five groups of islet cell tumors of the pancreas. Benign islet cell adenoma without hypoglycemia; Benign islet cell adenoma with hypoglycemia; Malignant islet cell carcinoma.

  • Antioxidant activity of chito-oligosaccharides on pancreatic islet cells in streptozotocin-induced diabetes in rats. Wen-Peng Yuan; Bing Liu; Chang-Heng Liu; Xiao-Jun Wang; Mian-Song Zhang; Xiu-Mei Meng; Xue-Kui Xia; Tarantino, Giovanni // World Journal of Gastroenterology;3/21/2009, Vol. 15 Issue 11, p1339 

    AIM: To investigate the antioxidant activity of chito-oligosaccharides (COSs) on pancreatic islet cells in diabetic rats induced by streptozotocin. METHODS: The antioxidant effect of COSs on pancreatic islet cells was detected under optical microscopy and with colorimetric assay and gel...

  • Detrimental effect of protracted hyperglycaemia on beta-cell neogenesis in a mouse murine model of diabetes Y. Guz et al.: Beta-cell neogenesis. Guz, Y.; Torres, A.; Teitelman, G. // Diabetologia;Dec2002, Vol. 45 Issue 12, p1689 

    Aims/hypothesis. Previous studies have shown that new beta cells differentiate from intra-islet precursors in pancreatic islets of mice in which diabetes is induced by injecting a high dose of the beta-cell toxin streptozotocin. Moreover, the re-establishment of euglycaemia by insulin therapy 1...

  • Insulinomas.  // British Medical Journal (Clinical Research Edition);3/21/1981, Vol. 282 Issue 6268, p927 

    Focuses on the effect of insulin-secreting islet-cell tumors of the pancreas (insulinomas) on hypoglycemia. Cardinal biochemical feature of an insulinoma; Use of tolbutamide or glucagon on provoking the tumour to release insulin; Treatment for the tumor.

  • eye tumours. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p293 

    An encyclopedia entry for "eye tumours" is presented. Eye tumours are rare and are usually painless and cancerous. Information is provided on the different types of eye tumours, including retinoblastoma, malignant melanoma, secondary eye tumours and basal cell carcinoma. The treatment options...

  • Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood. Verhoef, S.; van Diemen-Steenvoorde, R.; Akkersdijk, W. L.; Bax, N. M. A.; Ariyurek, Y.; Hermans, C. J.; van Nieuwenhuizen, O.; Nikkels, P. G. J.; Lindhout, D.; Halley, D. J. J.; Lips, K.; van den Ouweland, A. M. W.; Bax, N M; Nikkels, P G; Halley, D J; van den Ouweland, A M // European Journal of Pediatrics;1999, Vol. 158 Issue 4, p284 

    Unlabelled: A 12-year-old boy with tuberous sclerosis complex (TSC) presented with a large retroperitoneal tumour. Exploratory surgery revealed an infiltrative tumour originating from the pancreas, with local metastases to the lymph nodes. The histologal diagnosis was a malignant...

  • Role of Endogenous GLP-1 and GIP in Beta Cell Compensatory Responses to Insulin Resistance and Cellular Stress. Vasu, Srividya; Moffett, R. Charlotte; Thorens, Bernard; Flatt, Peter R. // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Role of GLP-1 and GIP in beta cell compensatory responses to beta cell attack and insulin resistance were examined in C57BL/6 mice lacking functional receptors for GLP-1 and GIP. Mice were treated with multiple low dose streptozotocin or hydrocortisone. Islet parameters were assessed by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics